CAH vs UFPT
CAH: Cardinal Health is a healthcare services and logistics company that distributes pharmaceuticals, medical supplies, and healthcare IT solutions to pharmacies, hospitals, and health systems globally. UFPT: A specialized contract manufacturer producing custom single-use and single-patient medical devices for major OEMs across minimally invasive surgery, wound care, orthopedics, and biopharma applications.
Side-by-side fundamentals
| Metric | CAH | UFPT | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $220.54 | $237.96 | |
| Market cap as of 2026-07-23 | $53.0B | $1.9B | |
| P/E as of 2026-07-23 | 34.07 | 27.03 | UFPT lower |
| PEG as of 2026-07-23 | 2.07 | 3.50 | CAH lower |
| Net margin as of 2026-07-23 | +0.6% | +11.3% | UFPT higher |
| Gross margin as of 2026-07-23 | +3.8% | +28.4% | UFPT higher |
| Operating margin as of 2026-07-23 | +0.9% | +15.2% | UFPT higher |
| ROE as of 2026-07-23 | +37.2% | +16.6% | CAH higher |
| ROA as of 2026-07-23 | +2.8% | +10.5% | UFPT higher |
| Debt / equity as of 2026-07-23 | 5.65 | 0.31 | UFPT lower |
| Revenue growth (YoY) as of 2026-07-23 | +12.9% | +11.2% | CAH higher |
| Revenue CAGR (3y) SEC XBRL | +7.1% | +22.7% | UFPT higher |
| Dividend yield as of 2026-07-23 | +0.9% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.53 | 1.07 | |
| 1-year return as of 2026-07-22 close | +43.2% | +3.0% | CAH higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.